Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group-Reference-Cited by-同舟云学术

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Published:2002-06 Issue:6 Volume:13 Page:866-873
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Comella P.,Crucitta E.,De Vita F.,De Lucia L.,Farris A.,Del Gaizo F.,Palmeri S.,Iannelli A.,Mancarella S.,Tafuto S.,Maiorino L.,Buzzi F.,De Cataldis G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/6/866/587353/mdf133.pdf

Reference23 articles.

1. New directions in the treatment of colorectal cancer a look to the future;Sobrero;Eur J Cancer,2000

2. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate;J Clin Oncol,1992

3. Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer;J Clin Oncol,1994

4. Concurrent modulation of 5-fluorouracil with methotrexate and l-leucovorin: An effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology Group;Comella;Tumori,1999

5. Sequential methotrexate, 5-fluorouracil (5-FU), and high-dose leucovorin versus 5-FU and high-dose leucovorin versus 5-FU alone for advanced colorectal cancer;Abad;Cancer,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-line systemic therapy for metastatic colorectal cancer;Cochrane Database of Systematic Reviews;2017-01-27

2. The impact of personalized medicine on survival: Comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers;Cancer Treatment Reviews;2014-05

3. Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer;Annals of Oncology;2013-01

4. Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience;Clinical Colorectal Cancer;2011-03

5. Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer;Cancer;2010-09-30